Stratos Wealth Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,489
Closed -$227K – 1202
2021
Q1
$227K Sell
1,489
-864
-37% -$131K 0.01% 992
2020
Q4
$303K Sell
2,353
-50
-2% -$5.75K 0.01% 846
2020
Q3
$269K Buy
+2,403
New +$220K 0.01% 823

Other funds holding GH

Stratos Wealth Partners's GH Position: Q2 2021 in Review

Stratos Wealth Partners sold out of Guardant Health (GH) in Q2 2021, closing a stake of 1,489 shares — an estimated $227K sold.

Stratos Wealth Partners first reported a position in GH in Q3 2020 and held it in 3 quarters. The position peaked at $303K in Q4 2020. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Stratos Wealth Partners reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,489 Guardant Health shares in Q2 2021, an estimated $227K.
  • Stratos Wealth Partners first reported a position in Guardant Health in Q3 2020 and held it in 3 quarters.
  • Stratos Wealth Partners's Guardant Health position peaked at $303K in Q4 2020.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Stratos Wealth Partners's 13F filing for Q2 2021, filed 19 Jul 2021.